Zobrazeno 1 - 10
of 1 210
pro vyhledávání: '"de Haard, H"'
Autor:
Ma G; Centre for Cancer Immunology, Faculty of Medicine, University of Southampton, Southampton, United Kingdom., Crowley AR; Centre for Cancer Immunology, Faculty of Medicine, University of Southampton, Southampton, United Kingdom., Heyndrickx L; argenx, Zwijnaarde, Ghent, Belgium., Rogiers I; argenx, Zwijnaarde, Ghent, Belgium., Parthoens E; VIB BioImaging Core, Center for Inflammation Research, Ghent, Belgium., Van Santbergen J; argenx, Zwijnaarde, Ghent, Belgium., Ober RJ; Centre for Cancer Immunology, Faculty of Medicine, University of Southampton, Southampton, United Kingdom., Bobkov V; argenx, Zwijnaarde, Ghent, Belgium., de Haard H; argenx, Zwijnaarde, Ghent, Belgium., Ulrichts P; argenx, Zwijnaarde, Ghent, Belgium., Hofman E; argenx, Zwijnaarde, Ghent, Belgium., Louagie E; argenx, Zwijnaarde, Ghent, Belgium., Balbino B; argenx, Zwijnaarde, Ghent, Belgium., Ward ES; Centre for Cancer Immunology, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
Publikováno v:
JCI insight [JCI Insight] 2024 May 07; Vol. 9 (10). Date of Electronic Publication: 2024 May 07.
Autor:
Goebeler M., Csörgő Sándorné Bata Zsuzsanna, De Simone C., Didona B., Remenyik Éva, Reznichenko N., Stoevesandt J., Ward E. S., Parys W., de Haard H., Dupuy P., Verheesen P., Schmidt E., Joly P., Kollaborációs szervezet: ARGX-113-1701 Investigator Study Group
Publikováno v:
The British journal of dermatologyReferences. 186(3)
Background: Pemphigus vulgaris and pemphigus foliaceus are potentially life-threatening autoimmune disorders triggered by IgG autoantibodies against mucosal and epidermal desmogleins. There is an unmet need for fast-acting drugs that enable patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69c6571578acb4ecf2bcd551a59cb532
https://pubmed.ncbi.nlm.nih.gov/34608631
https://pubmed.ncbi.nlm.nih.gov/34608631
Orally administered L. lactis secreting an anti-TNF Nanobody demonstrate efficacy in chronic colitis
Autor:
Vandenbroucke, K, de Haard, H, Beirnaert, E, Dreier, T, Lauwereys, M, Huyck, L, Van Huysse, J, Demetter, P, Steidler, L, Remaut, E, Cuvelier, C, Rottiers, P
Publikováno v:
In Mucosal Immunology January 2010 3(1):49-56
Site-specific 68 Ga-labeled nanobody for PET imaging of CD70 expression in preclinical tumor models.
Autor:
Dewulf J; Molecular Imaging Center Antwerp (MICA), Integrated Personalized and Precision Oncology Network (IPPON), Faculty of Medicine and Health Sciences, University of Antwerp, Universiteitsplein 1, 2610, Wilrijk, Belgium., Flieswasser T; Center for Oncological Research (CORE), Faculty of Medicine and Health Sciences, IPPON, University of Antwerp, Universiteitsplein 1, 2610, Wilrijk, Belgium., Delahaye T; argenx BV, Industriepark 7, Zwijnaarde, 9052, Gent, Belgium., Vangestel C; Molecular Imaging Center Antwerp (MICA), Integrated Personalized and Precision Oncology Network (IPPON), Faculty of Medicine and Health Sciences, University of Antwerp, Universiteitsplein 1, 2610, Wilrijk, Belgium.; Nuclear Medicine Department, Antwerp University Hospital, Drie Eikenstraat 655, 2650, Edegem, Belgium., Miranda A; Molecular Imaging Center Antwerp (MICA), Integrated Personalized and Precision Oncology Network (IPPON), Faculty of Medicine and Health Sciences, University of Antwerp, Universiteitsplein 1, 2610, Wilrijk, Belgium., de Haard H; argenx BV, Industriepark 7, Zwijnaarde, 9052, Gent, Belgium., Jacobs J; argenx BV, Industriepark 7, Zwijnaarde, 9052, Gent, Belgium., Smits E; Center for Oncological Research (CORE), Faculty of Medicine and Health Sciences, IPPON, University of Antwerp, Universiteitsplein 1, 2610, Wilrijk, Belgium., Van den Wyngaert T; Molecular Imaging Center Antwerp (MICA), Integrated Personalized and Precision Oncology Network (IPPON), Faculty of Medicine and Health Sciences, University of Antwerp, Universiteitsplein 1, 2610, Wilrijk, Belgium.; Nuclear Medicine Department, Antwerp University Hospital, Drie Eikenstraat 655, 2650, Edegem, Belgium., Elvas F; Molecular Imaging Center Antwerp (MICA), Integrated Personalized and Precision Oncology Network (IPPON), Faculty of Medicine and Health Sciences, University of Antwerp, Universiteitsplein 1, 2610, Wilrijk, Belgium. filipe.elvas@uantwerpen.be.
Publikováno v:
EJNMMI radiopharmacy and chemistry [EJNMMI Radiopharm Chem] 2023 Apr 24; Vol. 8 (1), pp. 8. Date of Electronic Publication: 2023 Apr 24.
Autor:
McCoy LE, Rutten L, Dekkers G, Blanchetot C, Strokappe NM, Forsman-Quigley A, Seaman MS, de Haard H, Verrips T, Weiss RA
Publikováno v:
Retrovirology, Vol 9, Iss Suppl 2, p P94 (2012)
Externí odkaz:
https://doaj.org/article/3a6599a0dfe74c328c50ffd0214d2fa4
Autor:
de Haard H, Weissenhorn W, Hinz A, Langedijk H, Weiss RA, Forsman A, Asaa-Chapman MM, Khatttabi ME, Liu Y, Verrips T
Publikováno v:
Retrovirology, Vol 6, Iss Suppl 3, p P332 (2009)
Externí odkaz:
https://doaj.org/article/dd4ff4a449bf45ceab17059241b6ec40
Autor:
Guptill JT; Department of Neurology, Duke University School of Medicine, Durham, North Carolina, USA.; argenx, Ghent, Belgium., Sleasman JW; Department of Pediatrics, Division of Allergy, Immunology, and Pulmonary Medicine, Duke University School of Medicine, Durham, North Carolina, USA., Steeland S; argenx, Ghent, Belgium., Sips M; argenx, Ghent, Belgium., Gelinas D; argenx, Ghent, Belgium., de Haard H; argenx, Ghent, Belgium., Azar A; Division of Allergy and Clinical Immunology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Winthrop KL; Division of Infectious Disease, Oregon Health and Science University, Portland, Oregon, USA.
Publikováno v:
Autoimmunity [Autoimmunity] 2022 Dec; Vol. 55 (8), pp. 620-631. Date of Electronic Publication: 2022 Aug 29.
Autor:
Vienot A; Department of Medical Oncology, University Hospital of Besançon, F-25000 Besançon, France.; INSERM, EFS BFC, UMR1098, RIGHT, University of Bourgogne Franche-Comté, Interactions Greffon-Hôte-Tumeur/Ingénierie Cellulaire et Génique, F-25000 Besançon, France.; Clinical Investigational Center, CIC-1431, F-25000 Besançon, France., Pallandre JR; INSERM, EFS BFC, UMR1098, RIGHT, University of Bourgogne Franche-Comté, Interactions Greffon-Hôte-Tumeur/Ingénierie Cellulaire et Génique, F-25000 Besançon, France., Renaude E; INSERM, EFS BFC, UMR1098, RIGHT, University of Bourgogne Franche-Comté, Interactions Greffon-Hôte-Tumeur/Ingénierie Cellulaire et Génique, F-25000 Besançon, France., Viot J; Department of Medical Oncology, University Hospital of Besançon, F-25000 Besançon, France.; INSERM, EFS BFC, UMR1098, RIGHT, University of Bourgogne Franche-Comté, Interactions Greffon-Hôte-Tumeur/Ingénierie Cellulaire et Génique, F-25000 Besançon, France., Bouard A; INSERM, EFS BFC, UMR1098, RIGHT, University of Bourgogne Franche-Comté, Interactions Greffon-Hôte-Tumeur/Ingénierie Cellulaire et Génique, F-25000 Besançon, France.; ITAC platform, University of Bourgogne Franche-Comté, F-25000 Besançon, France., Spehner L; INSERM, EFS BFC, UMR1098, RIGHT, University of Bourgogne Franche-Comté, Interactions Greffon-Hôte-Tumeur/Ingénierie Cellulaire et Génique, F-25000 Besançon, France., Kroemer M; INSERM, EFS BFC, UMR1098, RIGHT, University of Bourgogne Franche-Comté, Interactions Greffon-Hôte-Tumeur/Ingénierie Cellulaire et Génique, F-25000 Besançon, France.; ITAC platform, University of Bourgogne Franche-Comté, F-25000 Besançon, France., Abdeljaoued S; INSERM, EFS BFC, UMR1098, RIGHT, University of Bourgogne Franche-Comté, Interactions Greffon-Hôte-Tumeur/Ingénierie Cellulaire et Génique, F-25000 Besançon, France., van der Woning B; Argenx, 9052 Zwijnaarde, Belgium., de Haard H; Argenx, 9052 Zwijnaarde, Belgium., Loyon R; INSERM, EFS BFC, UMR1098, RIGHT, University of Bourgogne Franche-Comté, Interactions Greffon-Hôte-Tumeur/Ingénierie Cellulaire et Génique, F-25000 Besançon, France., Hervouet E; INSERM, EFS BFC, UMR1098, RIGHT, University of Bourgogne Franche-Comté, Interactions Greffon-Hôte-Tumeur/Ingénierie Cellulaire et Génique, F-25000 Besançon, France.; EPIgenetics and GENe EXPression Technical Platform (EPIGENExp), University of Bourgogne Franche-Comté, F-25000 Besançon, France., Peixoto P; INSERM, EFS BFC, UMR1098, RIGHT, University of Bourgogne Franche-Comté, Interactions Greffon-Hôte-Tumeur/Ingénierie Cellulaire et Génique, F-25000 Besançon, France.; EPIgenetics and GENe EXPression Technical Platform (EPIGENExp), University of Bourgogne Franche-Comté, F-25000 Besançon, France., Borg C; Department of Medical Oncology, University Hospital of Besançon, F-25000 Besançon, France.; INSERM, EFS BFC, UMR1098, RIGHT, University of Bourgogne Franche-Comté, Interactions Greffon-Hôte-Tumeur/Ingénierie Cellulaire et Génique, F-25000 Besançon, France.; Clinical Investigational Center, CIC-1431, F-25000 Besançon, France.; ITAC platform, University of Bourgogne Franche-Comté, F-25000 Besançon, France.
Publikováno v:
Oncoimmunology [Oncoimmunology] 2022 Nov 12; Vol. 11 (1), pp. 2144669. Date of Electronic Publication: 2022 Nov 12 (Print Publication: 2022).
Autor:
Brinkhaus M; Immunoglobulin Research Laboratory, Department of Experimental Immunohematology, Sanquin Research and Landsteiner, Amsterdam UMC, University of Amsterdam, 1066 CX, Amsterdam, The Netherlands.; Department of Biomolecular Mass Spectrometry and Proteomics, Utrecht Institute for Pharmaceutical Sciences and Bijvoet Center for Biomolecular Research, Utrecht University, Utrecht, The Netherlands.; argenx, 9052, Zwijnaarde, Belgium., Pannecoucke E; argenx, 9052, Zwijnaarde, Belgium.; Unit for Structural Biology, Department of Biochemistry and Microbiology, Ghent University, 9052, Ghent, Belgium.; Unit for Structural Biology, VIB-UGent Center for Inflammation Research, 9052, Ghent, Belgium., van der Kooi EJ; Immunoglobulin Research Laboratory, Department of Experimental Immunohematology, Sanquin Research and Landsteiner, Amsterdam UMC, University of Amsterdam, 1066 CX, Amsterdam, The Netherlands.; Department of Biomolecular Mass Spectrometry and Proteomics, Utrecht Institute for Pharmaceutical Sciences and Bijvoet Center for Biomolecular Research, Utrecht University, Utrecht, The Netherlands., Bentlage AEH; Immunoglobulin Research Laboratory, Department of Experimental Immunohematology, Sanquin Research and Landsteiner, Amsterdam UMC, University of Amsterdam, 1066 CX, Amsterdam, The Netherlands.; Department of Biomolecular Mass Spectrometry and Proteomics, Utrecht Institute for Pharmaceutical Sciences and Bijvoet Center for Biomolecular Research, Utrecht University, Utrecht, The Netherlands., Derksen NIL; Department of Immunopathology, Sanquin Research and Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, 1066 CX, Amsterdam, The Netherlands., Andries J; Unit for Structural Biology, Department of Biochemistry and Microbiology, Ghent University, 9052, Ghent, Belgium.; Unit for Structural Biology, VIB-UGent Center for Inflammation Research, 9052, Ghent, Belgium., Balbino B; argenx, 9052, Zwijnaarde, Belgium., Sips M; argenx, 9052, Zwijnaarde, Belgium., Ulrichts P; argenx, 9052, Zwijnaarde, Belgium., Verheesen P; argenx, 9052, Zwijnaarde, Belgium., de Haard H; argenx, 9052, Zwijnaarde, Belgium., Rispens T; Department of Immunopathology, Sanquin Research and Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, 1066 CX, Amsterdam, The Netherlands., Savvides SN; Unit for Structural Biology, Department of Biochemistry and Microbiology, Ghent University, 9052, Ghent, Belgium.; Unit for Structural Biology, VIB-UGent Center for Inflammation Research, 9052, Ghent, Belgium., Vidarsson G; Immunoglobulin Research Laboratory, Department of Experimental Immunohematology, Sanquin Research and Landsteiner, Amsterdam UMC, University of Amsterdam, 1066 CX, Amsterdam, The Netherlands. G.vidarsson@sanquin.nl.; Department of Biomolecular Mass Spectrometry and Proteomics, Utrecht Institute for Pharmaceutical Sciences and Bijvoet Center for Biomolecular Research, Utrecht University, Utrecht, The Netherlands. G.vidarsson@sanquin.nl.
Publikováno v:
Nature communications [Nat Commun] 2022 Oct 14; Vol. 13 (1), pp. 6073. Date of Electronic Publication: 2022 Oct 14.
Autor:
Goebeler, M., Bata‐Csörgő, Z., De Simone, C., Didona, B., Remenyik, E., Reznichenko, N., Stoevesandt, J., Ward, E.S., Parys, W., de Haard, H., Dupuy, P., Verheesen, P., Schmidt, E., Joly, P.
Publikováno v:
British Journal of Dermatology; Mar2022, Vol. 186 Issue 3, p429-439, 11p